Bluefish Pharmaceuticals

Bluefish Pharmaceuticals is a Stockholm-based, privately-held commercial-stage company specializing in generic pharmaceuticals. Operating across 13 European markets, it offers a portfolio of over 80 products derived from well-established generic substances, targeting a broad range of therapeutic areas. The company's strategy centers on selecting products nearing patent expiry and niche offerings, partnering with external development and manufacturing experts to ensure quality and cost-effectiveness. Its core mission is to drive down healthcare costs and improve patient access to essential medicines through competition.

Partnership-driven generic drug identification, development, and commercialization platform. Relies on network of third-party CDMOs/CMOs for development and manufacturing, focusing on regulatory strategy, market analytics, and supply chain efficiency.

Bluefish competes in the crowded European generic pharmaceuticals market against large global players (e.g., Teva, Sandoz, Viatris) and numerous regional/local generic companies. Competition is primarily on price, product portfolio breadth, supply reliability, and relationships with wholesalers and pharmacies.